Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Change in Account Payables (2016 - 2025)

Fennec Pharmaceuticals filings provide 12 years of Change in Account Payables readings, the most recent being -$1.2 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 96.65% to -$1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 359.59% increase, with the full-year FY2025 number at $1.4 million, up 359.59% from a year prior.
  • Change in Account Payables hit -$1.2 million in Q4 2025 for Fennec Pharmaceuticals, down from -$75000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.0 million in Q1 2025 to a low of -$1.8 million in Q2 2021.
  • Median Change in Account Payables over the past 5 years was $58000.0 (2023), compared with a mean of $125352.9.
  • Biggest five-year swings in Change in Account Payables: soared 1387.3% in 2021 and later tumbled 1405.17% in 2024.
  • Fennec Pharmaceuticals' Change in Account Payables stood at $477000.0 in 2021, then tumbled by 130.19% to -$144000.0 in 2022, then surged by 681.25% to $837000.0 in 2023, then plummeted by 174.79% to -$626000.0 in 2024, then tumbled by 96.65% to -$1.2 million in 2025.
  • The last three reported values for Change in Account Payables were -$1.2 million (Q4 2025), -$75000.0 (Q3 2025), and $661000.0 (Q2 2025) per Business Quant data.